Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Canadian (TSX) Biotech Industry Analysis

UpdatedOct 02, 2025
DataAggregated Company Financials
Companies25
  • 7D5.6%
  • 3M7.0%
  • 1Y16.3%
  • YTD-2.0%

The Biotech industry is up 5.6% in the last week, with Bright Minds Biosciences up 15%. During this same period, the ME Therapeutics Holdings underperformed, falling 13%. This means that the industry has gained 16% over the past year. In the next few years, earnings are forecast to decline by 6.1% annually.

Industry Valuation and Performance

Has the Canadian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 03 Oct 2025CA$2.0bCA$95.7m-CA$225,783,805.7124.7x-8.8x20.7x
Sun, 31 Aug 2025CA$1.6bCA$95.4m-CA$220,647,914.2528.5x-7.5x17.2x
Tue, 29 Jul 2025CA$1.6bCA$91.1m-CA$271,551,745.6822.6x-5.8x17.4x
Thu, 26 Jun 2025CA$1.5bCA$90.7m-CA$286,465,126.6822.2x-5.2x16.4x
Sat, 24 May 2025CA$1.5bCA$91.5m-CA$302,756,417.6823.1x-5.1x16.9x
Mon, 21 Apr 2025CA$1.4bCA$92.1m-CA$285,664,026.6619.5x-4.8x15x
Wed, 19 Mar 2025CA$1.5bCA$88.6m-CA$310,692,790.5920.5x-5x17.5x
Fri, 14 Feb 2025CA$1.7bCA$87.4m-CA$318,249,292.3224.8x-5.3x19.3x
Sun, 12 Jan 2025CA$1.5bCA$87.5m-CA$319,430,859.6524.5x-4.5x16.6x
Tue, 10 Dec 2024CA$1.5bCA$83.4m-CA$311,370,967.399.3x-4.7x17.7x
Thu, 07 Nov 2024CA$1.5bCA$80.4m-CA$282,436,032.118.4x-5.3x18.8x
Sat, 05 Oct 2024CA$1.0bCA$80.2m-CA$278,014,414.969.4x-3.7x12.8x
Mon, 02 Sep 2024CA$996.5mCA$80.2m-CA$281,082,242.3710.2x-3.5x12.4x
Wed, 31 Jul 2024CA$1.1bCA$76.2m-CA$338,546,803.6810.6x-3.3x14.7x
Fri, 28 Jun 2024CA$1.1bCA$76.8m-CA$339,992,492.6810.6x-3.2x14.3x
Sun, 26 May 2024CA$1.1bCA$77.1m-CA$368,268,249.4810.8x-3.1x14.6x
Tue, 23 Apr 2024CA$875.4mCA$79.5m-CA$301,686,831.1212.6x-2.9x11x
Thu, 21 Mar 2024CA$1.1bCA$91.6m-CA$320,710,419.7811.1x-3.4x12x
Sat, 17 Feb 2024CA$1.2bCA$93.1m-CA$323,294,236.1512.6x-3.6x12.4x
Mon, 15 Jan 2024CA$3.6bCA$86.2m-CA$516,253,628.006.8x-6.9x41.3x
Wed, 13 Dec 2023CA$3.7bCA$86.1m-CA$543,176,753.005.6x-6.8x43.1x
Fri, 10 Nov 2023CA$3.7bCA$89.0m-CA$543,530,334.007.9x-6.8x41.8x
Sun, 08 Oct 2023CA$3.8bCA$89.0m-CA$525,742,736.006.2x-7.3x43.1x
Tue, 05 Sep 2023CA$4.0bCA$87.4m-CA$509,846,291.006.1x-7.9x45.9x
Thu, 03 Aug 2023CA$4.0bCA$82.0m-CA$516,316,225.006.8x-7.7x48.8x
Sat, 01 Jul 2023CA$4.1bCA$81.6m-CA$516,922,296.0013.4x-7.8x49.7x
Mon, 29 May 2023CA$3.8bCA$86.6m-CA$608,028,469.0011.8x-6.3x44x
Wed, 26 Apr 2023CA$3.7bCA$83.9m-CA$600,252,041.0012.7x-6.2x44.6x
Fri, 24 Mar 2023CA$2.6bCA$90.9m-CA$624,760,654.009.4x-4.1x28.5x
Sun, 19 Feb 2023CA$2.9bCA$89.1m-CA$596,583,435.008.1x-4.8x32.4x
Tue, 17 Jan 2023CA$3.1bCA$87.5m-CA$525,633,766.0012x-5.9x35.3x
Thu, 15 Dec 2022CA$3.2bCA$88.5m-CA$578,245,056.007.4x-5.6x36.5x
Sat, 12 Nov 2022CA$3.2bCA$86.1m-CA$564,361,600.0014.8x-5.7x37.1x
Mon, 10 Oct 2022CA$3.1bCA$86.1m-CA$549,676,132.0014.7x-5.7x36.4x
Price to Earnings Ratio

-5.7x


Total Market Cap: CA$3.1bTotal Earnings: -CA$549,676,132.00Total Revenue: CA$86.1mTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Biotech Industry Price to Earnings3Y Average -5.4x202320242025
Current Industry PE
  • Investors are pessimistic on the Canadian Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 26.6x is higher than the industry's current PS ratio of 20.7x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Revenues for these companies have grown 3.6% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Canadian Healthcare industry?

CA Market0.89%
Healthcare5.26%
Biotech5.64%
Biotech5.64%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
HBP Helix BioPharmaCA$2.9191.4%
+CA$106.2m		155.3%PE-23.3x
DRUG Bright Minds BiosciencesCA$80.9514.6%
+CA$73.0m		5,641.1%PB11.1x
METX ME Therapeutics HoldingsCA$4.9022.5%
+CA$26.6m		40.0%PB78.7x
EPRX Eupraxia PharmaceuticalsCA$8.333.5%
+CA$13.6m		136.0%PE-9.9x
MSCL Satellos BioscienceCA$0.739.0%
+CA$11.1m		46.0%PB2.5x

Latest News

HBP
CA$2.91
Helix BioPharma
7D
91.4%
1Y
155.3%
SHRX
CA$0.25
Sharp Therapeutics
7D
-50.0%
1Y
n/a
EPRX
CA$8.33
Eupraxia Pharmaceuticals
7D
3.5%
1Y
136.0%
METX
CA$4.90
ME Therapeutics Holdings
7D
22.5%
1Y
40.0%
MDNA
CA$1.01
Medicenna Therapeutics
7D
7.4%
1Y
-50.7%
MSCL
CA$0.73
Satellos Bioscience
7D
9.0%
1Y
46.0%
ONCO
CA$1.60
Onco-Innovations
7D
-13.5%
1Y
n/a
EDT
CA$1.37
Spectral Medical
7D
-7.4%
1Y
136.2%
NRX
CA$0.94
NurExone Biologic
7D
-6.9%
1Y
62.1%
DRUG
CA$80.95
Bright Minds Biosciences
7D
14.6%
1Y
5,641.1%
TTI
CA$0.70
Thiogenesis Therapeutics
7D
-5.4%
1Y
4.5%
ATLE
CA$0.16
Atlas Energy
7D
-3.0%
1Y
-68.0%
CYTO
CA$0.20
Cytophage Technologies
7D
-18.0%
1Y
-18.0%
BCT
CA$17.80
BriaCell Therapeutics
7D
18.7%
1Y
-90.8%
MBX
CA$0.24
Microbix Biosystems
7D
-9.3%
1Y
-31.0%

Is Microbix Biosystems (TSE:MBX) A Risky Investment?

Aug 15
Is Microbix Biosystems (TSE:MBX) A Risky Investment?
RVX
CA$0.10
Resverlogix
7D
11.1%
1Y
81.8%